NASA Flight Facility Successfully Launches Nanosatellite

[Date Prev] [Date Next] [Thread Prev] [Thread Next] [Date Index] [Thread Index]

 



May 20, 2009

Ashley Edwards/Grey Hautaluoma 
Headquarters, Washington 
202-358-1756/0668 
ashley.edwards-1@xxxxxxxx, grey.hautaluoma-1@xxxxxxxx 

Rachel Prucey 
Ames Research Center, Moffett Field, Calif. 
650-604-0643 
rachel.l.prucey@xxxxxxxx 

Keith Koehler 
Goddard Space Flight Center, Wallops Flight Facility, Wallops Island, Va. 
757-824-1579 
keith.a.koehler@xxxxxxxx 

RELEASE: 09-114

NASA FLIGHT FACILITY SUCCESSFULLY LAUNCHES NANOSATELLITE

WALLOPS ISLAND, Va. -- NASA's PharmaSat nanosatellite successfully 
launched at 7:55 p.m. EDT Tuesday from NASA's Wallops Flight Facility 
and the Mid-Atlantic Regional Spaceport located at Wallops Island, 
Va. PharmaSat rode to orbit aboard a four-stage Air Force Minotaur 1 
rocket. Also aboard were the Air Force Research Laboratory's TacSat-3 
satellite and other NASA CubeSat Technology Demonstration 
experiments, which include three four-inch cubed satellites developed 
by universities and industry. 

PharmaSat will investigate the effects of antifungal agents on the 
growth of yeast in microgravity. This research could improve 
understanding of how microbes may become resistant to the drugs used 
to treat sick astronauts on long-duration space missions. 

"After a spectacular launch as a hitchhiker on the Tacsat-3 mission, 
we made contact with PharmaSat and confirmed that the spacecraft 
deployed successfully," said Bruce Yost, PharmaSat mission manager at 
NASA's Ames Research Center in Moffett Field, Calif. "The PharmaSat 
mission and science teams are now preparing to complete the 
experiment on the yeast cultures." 

Approximately 20 minutes after launch, PharmaSat separated from the 
Minotaur 1 rocket and entered low Earth orbit at an altitude of 
approximately 285 miles. About an hour after launch, NASA spaceflight 
engineers made contact with PharmaSat. After a spacecraft checkout 
period, ground controllers will command PharmaSat to initiate its 
biological experiment, which will last approximately 96 hours. 

Now that PharmaSat is activated and has begun transmitting radio 
signals to ground control stations at SRI International in Menlo 
Park, Calif., and Santa Clara University in California, it will send 
mission data to the NASA Mission Management Team at NASA's Ames 
Research Center. The nanosatellite could transmit data for as long as 
six months. 

The TacSat-3 launch was the third Minotaur vehicle launched from the 
Mid-Atlantic Regional Spaceport's launch pad 0B on the southern end 
of Wallops Island. Air Force Space Command's Space and Missile 
Systems Center's Space Development and Test Wing at Kirtland AFB, 
N.M., has overall management of the mission. 

The Exploration Technology Development Program in NASA's Exploration 
Systems Mission Directorate at NASA Headquarters in Washington funded 
the PharmaSat project. 

For information about PharmaSat, visit: 



http://www.nasa.gov/mission_pages/smallsats/pharmasat.html 


For more information about NASA and agency programs, visit: 



http://www.nasa.gov 

	
-end-



To subscribe to the list, send a message to: 
hqnews-subscribe@xxxxxxxxxxxxxxxxxxxxxx
To remove your address from the list, send a message to:
hqnews-unsubscribe@xxxxxxxxxxxxxxxxxxxxxx
[Index of Archives]     [JPL News]     [Cassini News From Saturn]     [NASA Marshall Space Flight Center News]     [NASA Science News]     [James Web Space Telescope News]     [JPL Home]     [NASA KSC]     [NTSB]     [Deep Creek Hot Springs]     [Yosemite Discussion]     [NSF]     [Telescopes]

  Powered by Linux